Epstein-barr virus antigen constructs
The present invention relates to an Epstein-Barr virus antigen construct. The invention provides an Epstein-Barr virus antigen polynucleotide, a polypeptide and a carrier. And an immunogenic composition comprising the same. The present invention relates to methods for treating and preventing Epstein...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
09.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to an Epstein-Barr virus antigen construct. The invention provides an Epstein-Barr virus antigen polynucleotide, a polypeptide and a carrier. And an immunogenic composition comprising the same. The present invention relates to methods for treating and preventing Epstein-Barr virus infection and Epstein-Barr virus-related diseases, including the use of Epstein-Barr virus antigen constructs to produce vaccines for the treatment and prevention of Epstein-Barr virus infection and Epstein-Barr virus-related diseases, such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus.
本发明涉及爱泼斯坦-巴尔病毒抗原构建体。本发明提供了爱泼斯坦-巴尔病毒抗原多核苷酸、多肽和载体;以及包含其的免疫原性组合物。其包括使用爱泼斯坦-巴尔病毒抗原构建体来产生疫苗用于治疗和预防爱泼斯坦-巴尔病毒感染和爱泼斯坦-巴尔病毒-相关的疾病,诸如多发性硬化症、类风湿性关节炎和系统性红斑狼疮。 |
---|---|
Bibliography: | Application Number: CN202410465677 |